Claremont CA (PRWEB) June 03, 2012
Synedgen Founder & CEO William P. Wiesmann, M.D. has been appointed by the Board of Trustees of Harvey Mudd College (HMC) as a Trustee Emeritus, the highest honor bestowed by the College. Wiesmann is the 14th of past board members to be appointed as a Trustee Emeritus.
Wiesmann has a long history with HMC, beginning in 1991 with his involvement with the HMC Engineering Clinic, an academic-year long research project where students try to solve technical problems for corporate clients. While Dr. Wiesmann was a Department Director at the Walter Reed Army Institute of Research, he sponsored the development of a life sciences automated system to study the effects of simulated gravity upon living cells in space. This system was one of the most successful methods for scientific repeatability in space and became one of the most flown shuttle projects in the history of the space shuttle program.
From 1999 to 2010, he served as a member of the HMC Board of Trustees, as well as a project liaison for the HMC Engineering Clinic, where he oversaw 11 Engineering projects focusing on novel medical device designs and computational systems. He interacted directly with students and faculty, helped to generate government funding opportunities for faculty, and brought his wealth of experiences into the research and learning environment.
Ziyad Duron, Department Chair and HMC Professor of Engineering commented, “The Department of Engineering is especially grateful to Dr. Wiesmann for his visionary support of our program. He brought a series of challenging, state-of-the-art projects to our undergraduates, and through his mentoring of both faculty and students, created opportunities typically reserved for graduate students and programs of larger scope. The Department wishes to acknowledge the invaluable support Dr. Wiesmann has provided to our students and faculty, and recognizes him for his dedication to undergraduate engineering education and for his innovative thinking that has led to numerous and important medical products for improving and saving lives.”
In 2005, Wiesmann founded BioSTAR West with HMC Professor of Chemistry Shenda Baker to conduct R&D on wound healing and infection control using chemically modified polysaccharides. In 2009, BioSTAR West merged with its manufacturing partner Hawaii Chitopure to form Synedgen Inc., an innovative, bio-pharmaceutical company that remains based in Claremont.
Wiesmann’s ties to the College and the community are strong; BioSTAR West/Synedgen has employed more than 20 HMC students and the HMC Departments of Engineering and Chemistry routinely utilize Synedgen’s laboratory facilities for student research. Two of his other companies, BioSTAR Inc. and AutoMedx Inc. have HMC graduates as their primary scientific leaders.
“I am highly honored by this nomination. For the past 20 years the enthusiasm and dedication of the faculty and students has been an important part of my education as well. The collaborative, innovative and creative atmosphere that is part of the HMC culture is impressive and is reflected in the quality of the students, the faculty and the vision of the College. I remain committed to the college and the community and look forward to helping HMC build upon its terrific successes,” stated Dr. Wiesmann.
Synedgen Inc. is an innovative biopharmaceutical company focused on developing novel therapies and products through its proprietary biomaterials technology platform. This platform technology provides the foundation for preventing bacterial growth and disruption of biofilms in human and environmental applications. Product development is targeted to specifically address unmet needs for therapies that treat and prevent infections, primarily from bacteria that have developed resistance to traditional antibiotics.
Synedgen’s Corporate Headquarters and Research Laboratories are in Claremont CA; Synedgen’s Manufacturing Facility is in Honolulu HI. Additional information can be found at Synedgen’s web site at http://www.synedgen.com